Clinical Trial Update: A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [Phase 1, Phase 2]

View source ↗

Summary

Results from a Phase I/II trial of BMS-247550 for recurrent high-grade gliomas have been posted, evaluating adults with anaplastic astrocytoma, giant cell gliob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Giant Cell Glioblastoma
• Gliosarcoma
• High-grade Glioma

Drugs mentioned

• BMS-247550

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Giant Cell Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-09